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1571 ABSTRACT 
The performance of a waste-water reclamation system 
is monitored by introducing a non-pathogenic marker 
virus, bacteriophage F2, into the waste-water prior to 
treatment and, thereafter, testing the reclaimed water 
for the presence of the marker virus. A test sample is 
first concentrated by absorbing any marker virus onto a 
cellulose acetate filter in the presence of a trivalent 
cation at low pH and then flushing the filter with a 
limited quantity of a glycine buffer solution to desorb 
any marker virus present on the filter. Photo-optical 
detection of indirect passive immune agglutination by 
polystyrene beads indicates the performance of the 
water reclamation system in removing the marker virus. 
A closed system provides for concentrating any marker 
virus, initiating and monitoring the passive immune 
agglutination reaction, and then flushing the system to 
prepare for another sample. Peristaltic pumps are pro- 
vided for volumetric control and for positive fluid dis- 
placement. Solenoid valves direct the output from the 
pumps in preselected routes to accomplish the process 
for concentrating and detecting the marker virus. 
16 Claims, 3 Drawing Figures 
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WATER SYSTEM VIRUS DETECHON 
ORIGIN OF THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and is sub- 
ject to the provisions of 8 305 of the National Aeronau- 
tics and Space Act of 1958, Public Law 85-568 (72 
Stat.435; 45 USC 2457). 
BACKGROUND OF THE INVENTION 
This invention relates to performance monitoring of a 
waste-water reclamation system, and more particularly 
to monitoring the performance of a waste-water recla- 
mation system in removing a known marker virus by 
injecting a known quantity of the marker virus up- 
stream and detecting the presence of the virus down- 
stream from the reclamation system. 
In a closed environment system, such as exists in a 
spacecraft, it is necessary to recycle waste products to 
the maximum extent in order to fully utilize all the 
expendable products carried on board. Water is a par- 
ticular commodity which must be recycled because of 
the space and weight required to carry large amounts. 
Waste-water for recycling is available from such 
sources as wash water, urine, and environmental humid- 
ity. 
There are many systems well known in the prior art 
which can treat the above sources of waste water to 
remove the waste products and provide a recycled 
source of water. It is necessary, however, to monitor 
performance of any reclamation system in order to 
insure that the reclaimed water is indeed free of contam- 
ination and, in particular, free from pathogenic viruses 
which could contaminate the crew members. 
Since the presence of a virus in the purification sys- 
tem output is potentially the most dangerous result of a 
system malfunction, it is desirable to monitor the output 
for the presence of a virus. The particular virus selected 
for monitoring must be such that it will survive any 
waste-water environment and be generally a worse-case 
virus with respect to the ability of the purification sys- 
tem to remove the virus. The system output is then 
monitored for the presence of the selected virus. It is 
desirable that the monitoring system be able to detect a 
very low level of failure in the purification system while 
retaining a high degree of simplicity and reliability. 
It is an object of the present invention to detect the 
presence of a marker virus in reclaimed water. 
It is yet another feature of the present invention to 
monitor the performance of a waste water reclamation 
system whereby early detection of any system malfunc- 
tion is obtained. 
It is yet another feature of the present invention to 
process the sample from the output of the purification 
system in a closed detection system to monitor system 
berformance. 
It is a feature of the present invention to detect the 
presence of a known virus in the output of a waste 
water reclamation System to Wertain the possible pres- 
ence of pathogenic viruses in the output. 
itoring system capable of being incorporated in a space- 
craft and retaining its efficacy over extended periods of 
time. system. 
In the Drawings 
FIG. 1 is a simplified schematic diagram of the re- 
claimed water virus detection system according to one 
FIG. 2 is an elevation view, partly in cross-section, of 
an optical detector assembly utilized in the detection 
Still another feature of the present invention is a mon- 65 embodiment of the present invention. 
SUMMARY OF THE INVENTION 
A monitoring method and system is presented to test 
the capability of a water reclamation system to reject 
5 the passage of viruses with the reclaimed water. In a 
preferred embodiment of the method which is the sub- 
ject of the present invention, a non-pathogenic marker 
virus is fed into the process stream upstream of the 
water recovery unit and the reclaimed water is tested to 
10 determine the absence of the marker virus. The marker 
virus selected, bacteriophage F2, provides for a worst- 
case condition so that the absence of the marker virus in 
the reclaimed water provides assurance of the absence 
of any naturally occurring human pathogenic viruses. A 
15 failure in the water reclamation system will result in the 
passage of some quantity of marker virus through the 
system. It is contemplated by the present invention to 
detect the passage of only 1/1O,OOO of the marker virus 
present in the waste water. 
Detection of the marker virus in the downstream 
water consists of two major steps: (1) concentrating any 
marker virus which may be present and (2) obtaining an 
indication of the presence of the virus. Concentrating 
the marker virus requires that the virus be first removed 
25 from the reclaimed water sample. This is accomplished 
by adsorbing the marker virus onto the surface of a 
cellulose acetate fdter in the presence of a low pH solu- 
tion with a trivalent cation. A limited quantity of a high 
pH buffer solution is then passed through the cellulose 
30 fdter to desorb any marker virus on the filter surface 
and thereby obtain an increased concentration of virus 
in the sample passed to the detection step. 
An indication of the presence of marker virus in the 
buffer solution is now obtained utilizing the passive 
35 immunological reaction which occurs between a virus 
and the antibody for that virus. The presence of the 
reaction may be detected by a method known as passive 
immune agglutination wherein small latex or polysty- 
rene beads are coated with the virus or antibody and 
40 dispersed in a suitable medium. This dispersion is then 
mixed with a solution to be tested. If the test solution 
contains material reactive with the material on the 
beads, the reaction will cause the beads to agglutinate. 
The occurrence of agglutination will change the light 
45 transmittance of the bead dispersion which can be de- 
tected by means of conventional optical detection 
equipment. 
BRIEF DESCRIPTION OF THE DRAWINGS 
In order that the manner in which the above recited 
features of the invention are obtained can be understood 
in detail, a more particular description of the invention 
may be had by reference to the specific embodiment 
thereof which are illustrated in the appended drawings, 
55 which drawings form a part of this specification. It is to 
be noted, however, that the appended drawings illus- 
trate only typical embodiments of the invention and, 
therefore, are not to be considered limiting of its scope 
for the invention may admit to further equally effective 
20 
50 
60 embodiments. 
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FIG. 3 is a simplified schematic of a system for moni- 
toring the optical detector output. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
The reclaimed water virus detection system which is 
the subject of the present invention embodies the intro- 
duction of a sufficient concentration of a marker virus 
upstream of a purification system and the subsequent 
downstream detection of any remaining marker virus 
such that a failure in the purification system can be 
promptly detected. To provide adequate protection, it 
is desirable that the system be able to detect the passage 
of only 1/1O,OOO of the marker virus introduced up- 
stream of the purification system. 
The quantity of marker virus to be added to each 
batch of waste water to be reclaimed must be such that 
the desired 1/1O,OOO reduction factor for detection can 
be achieved. The svstem which is the subiect of the 
5 
10 
15 
present invention, a id  hereinbelow described, can de- 20 
tect a concentration of marker virus of 1 x 109PFU/ml 
(plaque forming units per milliliter) in the detection 
sample. The detection sample is derived from a test 
sample of the reclamation system output wherein the 
concentration of marker virus is increased by 100 times. 25 
Accordingly, the presence of only 1 X lo7 PFU/ml of 
marker virus in the reclaimed water can be detected. 
Since this is to represent a reduction of 1 X from 
an input concentration, the input concentration of 
marker virus to the reclamation system must be 1 X 30 
10l1 PFU/mP. If the volume of waste water is known, 
then the quantity of marker virus necessary to add to 
the waste water to yield the input concentration can be 
easily determined. 
tion system is known as bacteriophage F2. This virus is 
non-pathogenic to humans so no danger of contamina- 
tion exists from this viral source. Further, the selected 
virus is about the same size as, or smaller then, patho- 
genic viruses commonly encountered in humans and 40 
possesses a relatively high resistance to possible envi- 
ronmental conditions imposed by the water reclamation 
process, thereby lending itself to an ideal “worst-case” 
test. 
fied schematic of the reclaimed water virus detection 
system which is the subject of the present invention. 
Reclaimed water 10 is first presented to the detection 
system after being passed from the waste storage tank 5 
through the water treatment system 7. The object of the 50 
method and apparatus, hereinbelow discussed, is to 
detect the presence of any marker virus remaining in the 
water after the purification process. In fact, the detec- 
tion system determines the presence of the marker virus 
in the system by providing a positive indication of the 55 
absence of the virus. 
Waste water from various sources, such as wash wa- 
ter, body waste and atmospheric maintenance systems, 
is accumulated in storage tank 5 until a sufficient quan- 
tity is available to process through the treatment sys- 60 
tem. Just prior to treatment, marker virus injection 
system 6 injects a sufficient quantity of marker virus to 
provide a marker virus concentration of 1 X 10” 
PFU/ml in the input to water treatment system 7. 
claimed water sample must be treated to concentrate 
any marker virus for presentation to the remainder of 
the system. The concentration step is accomplished by 
The marker virus selected for use in the virus detec- 35 
Referring now to FIG. 1, there may be seen a simpli- 45 
In the first step of the monitoring process, the re- 65 
4 
using a cellulose acetate filter 16 to adsorb the marker 
virus on the filter surface as the sample is passed 
through the filter. A suitable filter may be obtained 
from Millipore Corporation with a porosity of 0.45 
microns and a diameter of 25 mm. T o  aid the adsorption 
of the marker virus onto the filter, a trivalent cation in 
a low pH solution is mixed with the waste water sample 
for presentation through the filter. A suitable trivaIent 
cation has been found to be aluminum chloride (A1Cl3). 
A preferred waste water solution contains 5 mM alumi- 
num chloride and acid to achieve a pH of 2.5-3.0 in the 
sample. Satisfactory adsorption of the marker virus 
onto filter 16 is achieved with a solution of 0.5 mM 
AE13 but an increased concentration of 5.0 mM A l a 3  
enhances marker virus adsorption under certain waste 
water conditions. 
Referring again to FIG. 1, sample pump 11 is acti- 
vated to turn peristaltic rotor 12 to pump in the desired 
volume of reclaimed water sample with any marker 
virus and simultaneously turn peristaltic rotor 13 to 
introduce the low pH aluminum chloride from tank 14. 
The solution comprising the reclaimed water and triva- 
lent cation flows through cellulose acetate filter 16 and 
three-way valve 17 which is actuated to direct the solu- 
tion into catch tank 18. As the solution flows through 
filter 16, any marker virus are adsorbed onto the surface 
of the filter. 
In the final step of the concentration process, a small 
quantity of a suitable buffer solution is next flowed 
through the cellulose acetate filter 16 to desorb the 
marker virus from the filter. In this step, valve 17 is 
activated to direct the fluid flow to the syringe portion 
42 of optical detector assembly 40. Reagent pump 21 is 
actuated to drive peristaltic rotor 22, and valve 24 is 
opened for allowing the buffer solution from buffer 
supply tank 23 to flow through filter 16. A suitable 
buffer solution is 0.05 M glycine at a pH of 11.5 with a 
quantity of about 3 ml. pumped through filter 16. It has 
been found that the recovery of marker virus is en- 
hanced if about 1 ml. is pumped through the filter and 
thereafter the remaining 2 ml. pumped through after a 
short delay period. Any marker virus collected on the 
cellulose acetate filter 16 are thereby removed in a con- 
centrated form with the buffer solution and pumped 
into syringe 42. 
Any marker virus concentrated in the test sample 
must now be detected. The method chosen for detec- 
tion of the virus is the passive immune agglutination 
(PIA) technique. The basic theory behind the PIA 
method is that a link is developed between a virus and 
the antibody for that virus. If the virus or the virus 
antibody is first placed on small plastic beads in a sus- 
pension and the beads are then subjected to a solution 
containing the antigen of the bead coating, cross links 
develop between the material on the beads and the 
material in solution and cause the beads to agglutinate. 
This agglutination changes the light transmission char- 
acteristics of the resulting mixture and the agglutination 
can thus be detected either visually or by photo-optical 
instrumentation. In the direct PIA method, the beads 
are coated with the antibody and then exposed to the 
virus. If the mixture is then incubated, and the virus is 
present, the antibodies on the beads will cross link with 
the virus in the sample and bead agglutination will oc- 
cur. Although the direct PIA technique provides a 
positive indication of the presence of the marker virus 
over a certain range of concentrations, a secondary 
effect occurs which makes this method less desirable. If 
5 
a large amount of marker virus is present, all of the 
antibodies on a given bead become complexed with the 
virus so that cross linking and agglutination do not 
occur and a false negative indication is obtained. 
For the above reason, an indirect PIA method was 
selected as the preferred embodiment. In this method 
the beads are generally latex or polystrene beads of 
about 1.1 micron diameter and are first coated with the 
marker virus. The concentrated test sample is mixed 
with a solution containing a predetermined concentra- 
tion of the virus antibody selected to match the concen- 
tration of virus to be detected and the mixture is incu- 
bated for a predetermined time. The virus coated beads 
are then introduced to the incubated mixture. If a virus 
is present in the sample, the antibodies are neutralized 
and no antibodies are available to cross link with the 
virus on the beads. If there is no virus in the test sample, 
antibodies remain available to react with the marker 
virus on the beads and cause annlutination of the beads. 
4.11 8,3 15 
Thus, the absence of a sufii&&t quantity of marker 20 
virus generates a positive indication, Le., bead clumping 
or agglutination, 
. 1, the PIA test is initiated 
simultaneously with desorption of the marker virus 
from filter 16. When reagent pump 21 is actuated, peri- 25 
staltic rotors 26 and 27 pump the antibody solution from 
tank 28 and the virus coated bead solution from tank 29, 
respectively. Three-way valve 31 is first energized to 
allow a predetermined amount of antibody solution into 
syringe 42 to react with any marker virus concentrated 30 
in the test sample. Valve 32 is energized thereafter to 
allow a predetermined amount of bead solution into the 
reacted solution. These solutions are all collected in 
syringe 42 along with the buffer solution containing any 
marker virus desorbed from filter 16. 
The sensitivity of the system is determined by the 
tendency of the beads to agglutinate in the presence of 
free antibodies. This tendency is functionally related to 
the concentration of the antibodies in the s 
also to the dilution of the beads in suspen 
Referring again to 
35 
been found that the ability to detect bead agglutination 
is optimum at a bead dilution of about 1:1,OOO from a 
stock concentration of about 3-5 mg/ml. However, it 
has also been determined that agglutination does not 
readily occur in this system with bead dilutions over 
1:900. Therefore, a bead dilution of 1:900 was selected 
for the preferred embodiment. The antibody concentra- 
tion is matched to the upper level of virus concentration 
which the system must be able to detect. The higher the 
antibody concentration, the higher the detection thresh- 
old for the system. It has been determined that an anti- 
body dilution of 1:3,200 from a stock concentration of 
antibody and combined with the optimum bead dilution 
provides the desired system detection capability. 
virus-coated beads and the antibodies are both 
in solutions of 0.1 M glycine, 1% NaCl pH 8.2. 
If it is desired to maintain the marker virus and antibod- 
ies for extended time periods, the resulting solutions 
may be refrigerated to a temperature of about 4" C. for 
storage. 
Referring yet again to FIG. 1, the solution containing 
free antibodies, if any, and coated beads is contained in 
syringe 42 within optical detector assembly 40 where it 
is maintained at a temperature of 45" C. by heater 43 for 
5 hours. Light source 45 directs light through the incu- 
bated sample to a detector 47 for measuring the change 
in light transmittance through the sample. The base 
light transmittance is taken as the light transmittance at 
45 
50 
55 
60 
65 
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the beginning of the incubation time and the change in 
light transmittance is measured as a function of time. 
The effect of agglutination is to increase the light trans- 
mittance and, hence, the effect of an operable purifica- 
tion system is a positive indication of agglutination. 
Referring now to FIG. 2, there may be seen an eleva- 
tion view, in partial cross-section, of an optical detector 
assembly used to detect agglutination of the beads. Op- 
tical detector assembly 40 generally includes a housing 
assembly 41 in which all the components are mounted 
and is secured to a suitable protective package. The 
sample for the PIA test is contained in syringe 42 
mounted in housing 41. A light source 45 is provided 
and the light output is directed to a beam splitter 46. 
One output from the beam splitter 46 is directed to 
photo-detector 49 and used as a feedback signal to main- 
tain a constant light intensity from light source 45 
through conventional electronic circuitry wherein the 
output from detector 49 is increased by amplifier 51 and 
passed to integrator 53 for comparison with a reference 
in voltage control circuit 55 to regulate the voltage 
supplied to light source 45. Another portion of the light 
beam from beam splitter 46 is directed through the 
solution in syringe 42. The light transmitted through 
syringe 42 is detected by photo-detector 47 and pro- 
cessed through conventional electronic circuitry, dis- 
cussed hereinbelow to obtain an output indication of the 
light transmittance. The reference light transmittance is 
that transmittance at the beginning of the incubation 
period. Heater 43 is activated to maintain the test sam- 
ple at about 45" C. during the 5 hour incubation period. 
The light transmittance is monitored throughout the 
incubation period to ascertain the occurrence of agglu- 
tination of the beads. As hereinabove explained, the 
occurrence of agglutination indicates the absence of 
marker virus in the reclaimed water sample. 
Referring now to FIG. 3, there may be seen a simpli- 
fied schematic of a circuit to detect.changes in the out- 
put of photo-detector 47. At the beginning of the incu- 
bation period, a reference signal is generated by refer- 
ence circuit 71. When a predetermined change in the 
light transmittance through syringe 42 has occurred, the 
output from comparator 72 will be sufficient to trigger 
threshold circuit 75. The output from threshold circuit 
75 drives circuits 76 and 78 which provide a positive 
and negative signal respectively. The occurrence of a 
positive signal to circuit 76 results in a positive indica- 
tion 77 of the presence of marker virus. Similarly, the 
occurrence of a negative signal to circuit 78 results in a 
negative indication 79, i.e., the absence of marker virus. 
Referring again to FIG. 1, the remaining steps in the 
process include removing the incubated test sample and 
preparing the system to receive another sample. Ac- 
cordingly, waste pump 61 is activated to turn peristaltic 
rotor 62 to pump the incubated sample material back to 
the waste tank 5 in the reclamaion system. Subse- 
quently, rinse pump 65 is activated to turn peristaltic 
rotor 66 to flush the original test sample material 
through the system. Valve 67 is opened and the material 
contained in holding tank 18 is pumped through valve 
17 and filter 16 to regenerate the filter and out through 
valve 67 to return to the purification system for repro- 
cessing. The system is now flushed and ready to receive 
another test sample. 
In the preferred operation of the detection system, 
after a selected concentration of marker virus is injected 
upstream of the water purification system 7, a 400 ml. 
processed water sample is pumped through cellulose 
7 
4,l P8,3 15 
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acetate filter (25 mm.) 16 at 20 ml. per minute and col- 
lected in tank 18. Before passing through filter 16, an 
aluminum chloride and acid concentrate is added at 0.5 
ml. per minute which lowers the pH to 2.5-3.0 and adds 
5 mM A1Cl3. Following the initial 400 ml. of treated 
sample, an additional 10 ml. of untreated sample is 
pumped through the filter to remove residual aluminum 
chloride, which has been shown to interfere with the 
PIA detection system. To remove any virus adsorbed 
on filter 16, 3.0 ml. of 0.05 M glycine buffer, PI-I 11.5, is 
pumped through filter 16 at 30 ml. per minute. The first 
milliliter is pumped through and collected in syringe 42, 
with the next 2 milliliters collected after a 1 minute 
delay. This delay was incorporated since it appears to 
increase the overall efficiency of marker virus desorp- 
tion. To the 3.0 ml. marker virus concentrate in syringe 
42, 1.0 ml. of a predetermined dilution of marker virus 
antibody is added and the mixture incubated for & hour 
at 45" C. Following this reaction period, 1.0 ml. of a , 
20 predetermined dilution of 1.1 micron latex or polysty- 
rene beads coated with marker virus is added and a 
spectro-photometric reading is made to determine the 
base light transmission of the suspension. The mixture is 
then incubated for 5 hours at 45" C., during which the 25 
light transmission through the solution is compared 
with the original reading. An increase in light transmis- 
sion is indicative of bead agglutination and, therefore, 
the absence of marker virus in the concentrate. 
ously be made in the structure herein described without 
departing from the present invention. Accordingly, it 
should be clearly understood that the forms of the in- 
vention herein described and shown in the figures of the 
accompanying drawings are illustrative only and are 35 
not intended to limit the scope of the invention. 
Numerous variations and modifications may obvi- 3o 
What is claimed is: 
1. A process for monitoring the performance of a 
water recovery purification system in removing patho- 
genic viruses, said process comprising the steps of: 40 
detecting the reaction between said antibody and said 
virus to indicate a failure in said purification sys- 
tem. 
4. The process as described in claim 3, wherein the 
5 step of reacting said antibody and said virus comprises 
the steps of: 
preparing a suspension containing inert beads coated 
with said antibody at a predetermined concentra- 
tion, and 
exposing said bead suspension to said concentrated 
sample to obtain a passive immune agglutination of 
said beads if a preselected concentration of said 
marker virus is present in said concentrated sample. 
5. The process as described in claim 3, wherein the 
15 step of reacting said antibody and said virus comprises 
preparing a suspension containing inert beads coated 
with said marker virus at a predetermined concen- 
tration. 
10 
the steps of: 
reacting a solution of said concentrated sample and a 
solution containing a predetermined concentration 
of said antibody, thereafter mixing said bead sus- 
pension with said reacted sample to form a detec- 
tion sample, and 
incubating said detection sample to obtain a passive 
immune agglutination of said beads if the concen- 
tration of said marker virus in said concentrated 
sample is below a preselected level. 
6. The process as described in claim 5, wherein the 
step of detecting said reaction between said marker 
virus and said antibody comprises the steps of: 
measuring the light transmittance of said incubating 
detection sample at the beginning of said incuba- 
tion, 
continuing to incubate said detection sample for a 
predetermined time to produce a passive immuni- 
zation reaction, and 
measuring the light transmittance of said incubating 
detection sample to detect a change in said light 
transmittance resulting from a passive immune 
introducing a non-pathogenic bacteriophage marker 
virus at a predetermined concentration upstream of 
said water recovery system; 
collecting a sample of effluent from said water recov- 
ery system; 
concentrating any marker virus present in said efflu- 
ent sample by mixing said sample with a solution 
containing a trivalent cation formed from a solu- 
tion containing AlC& to obtain a resulting mixture 
with a pH of 2.5-3.5, 
passing said resulting mixture through a cellulose 
acetate filter to adsorb any of said marker virus 
onto said filter, and thereafter 
desorbing any of said marker virus from said filter by 
passing a selected quantity of a buffer solution 
through said filter to form a solution containing an 
increased concentration of said virus; and 
testing said concentrated sample for said marker virus 
to monitor said water recovery purification system. 
2. The process as described in claim 1, including the 
step of forming said trivalent cation from a solution 
containing 0.5-5.0 mM AlCl,. 
3. The process as described in claim 1, wherein the 
step of testing said concentrated sample comprises the 
steps of: 
reacting an antibody of said marker virus with said 
marker virus to determine the presence of said 
marker virus in said concentrated sample, and 
agglutination within said incubating detection sam- 
ple. 
7. The process as described in claim 1, wherein said 
8. A process for monitoring the presence of a known 
mixing said sample with a solution containing a triva- 
lent cation formed from a solution containing 
AlCl, to obtain a resulting mixture with a pH of 
passing said resulting mixture through a cellulose 
acetate filter to adsorb any of said virus onto said 
filter, 
desorbing any of said known virus from said filter by 
passing a limited quantity of a buffer solution 
through said filter to form a concentrated solution 
containing said virus, 
reacting an antibody of said known virus in said con- 
centrated sample, and 
photo-optically detecting the reaction between said 
antibody and said virus to indicate the presence of 
said known virus in said sample. 
9. The process as described in claim 8, wherein the 
step of reacting said antibody and said virus comprises 
preparing a suspension containing inert beads coated 
with said antibody at a predetermined concentra- 
tion, and 
marker virus is bactriophage F,. 
virus in a water sample, comprising the steps of: 
45 
50 2.5-3.5, 
55 
60 
65 the steps of: 
9 
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exposing said bead suspension to said concentrated 
sample to obtain a passive immune agglutination of 
said beads if a preselected concentration of said 
known virus is present in said concentrated sample. 
10. The process as described in claim 8, wherein the 
step of reacting said antibody and said known virus 
comprises the steps of: 
preparing a suspension of inert beads coated with said 
known virus at a predetermined concentration, 
reacting a solution of said concentrated sample and a 
solution containing a predetermined concentration 
of said antibody, 
mixing said bead suspension with said reacted sample 
to form a detection sample, 
incubating said detection sample to obtain a passive 
immune agglutination of said beads if the concen- 
tration of said known virus in said concentrated 
sample is below a preselected level. 
11. The process, as described in claim 10, wherein the 20 
15 
step of photo-optically detecting the reaction between 
said antibody and said virus includes: 
measuring the initial light transmittance of said incu- 
bating detection sample to obtain a reference trans- 
mittance, 
continuing to incubate said detection sample for a 
predetermined time at a preselected temperature to 
produce passive immune agglutination of said 
beads, and 30 
measuring the light transmittance of said incubating 
detection sample to detect an increase in said light 
transmittance which indicates the occurrence of 
passive immune agglutination and the absence of 
the known virus. 35 
12. A system for monitoring the performance of a 
water recovery purification system for removing patho- 
genic viruses, comprising: 
means for introducing a selected marker virus at a 
25 
predetermined concentration upstream of said 40 
water recovery system, 
a source of a low pH solution containing a trivalent 
cation, 
a first pump cooperating with said source of a low pH 45 
solution for mixing a sample of emuent from said 
water recovery system with a predetermined quan- 
tity of said low pH solution, 
a filter receiving the mixed output from said first 
pump for adsorbing any of said marker virus pres- 50 
ent in said eMuent sample, 
a source of a buffer solution, 
10 
a source of a solution containing an antibody for said 
marker virus, 
a source of a suspension of beads coated with said 
marker virus, 
valve means for receiving the outputs of said sources 
of said buffer solution, said virus antibody solution 
and said suspension of marker virus coated beads 
for selectively passing each of said buffer solution, 
virus antibody solution, and suspension of marker 
virus-coated beads, 
sample collection means, 
a second pump interconnected between said valve 
means, said filter and said sample collection means 
and cooperating with said valve means for first 
pumping a selected quantity of said buffer solution 
through said filter to desorb said marker virus from 
said filter to form a concentrated sample solution of 
marker virus deposited in said sample collection 
means, and then pumping predetermined quantities 
of said virus antibody solution and said suspension 
of marker virus-coated beads into said sample col- 
lection means for mixing with said concentrated 
virus sample, 
heating means cooperating with said sample collec- 
tion means for incubating said collected sample to 
produce passive immune agglutination of said 
beads, and 
photo-optical detector means cooperating with said 
sample collection means for monitoring the light 
transmittance through said incubating collected 
sample and detecting the increase in said light 
transmittance caused by passive immune agglutina- 
tion. 
13. The system, as described in claim 12, wherein said 
first and second pump means each comprise peristaltic 
pumps. 
14. The system as described in claim 12, wherein said 
filter comprises a cellulose acetate membrane. 
15. The system as described in claim 12, wherein said 
sample collection means comprises a syringe for receiv- 
ing and holding the collected sample solution. 
16. The system as described in claim 12, wherein said 
photo-optical detector means further comprises: 
a light source for directing a beam of light through 
said syringe and said incubating collected sample, 
and 
detector means disposed opposite said syringe from 
said light source for receiving said light beam and 
deriving an indication of an increase in light trans- 
mittance due to a positive immune agglutination of 
said beads within said syringe. * * * * *  
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